98319-26-7 Finasteride

Pwopriyete

Aparans blan yo bèlj solid
Pwen k ap fonn: 253 degre
Alpha 405 -59 degre (C=1 nan methanol)
Pwen bouyi: 576.6 ± 5 0. 0 degre
Dansite 1. 0 65 ± 0.06 g/cm3
Solubility DMSO: 32 mg/ml, soluble
Solubilite dlo soluble

 

Aplikasyon:

Finasteride se yon 5 - rediktaz inibitè prensipalman itilize nan trete kalvisi modèl gason ak ipèrplasya pwostat benen. Li travay pa anpeche pwodiksyon an nan dihydrotestosterone (DHT) ak mande pou alontèm administrasyon oral ak konsèy medikal pou medikaman. Efè segondè komen yo enkli malfonksyònman seksyèl ak malèz gastwoentestinal, epi yo kontr pou fanm ansent, timoun yo, ak moun ki gen alèji.

 

Sinonim:

finasteride

98319-26-7

Mk -906

Finasterida

Finpecia

Finasteridum

Finasterida

Mk -0906

N-tert-butil -3- oxo -4- aza -5 alfa-androst -1- ENE -17 beta-carboxamide

(5alpha, 17beta)-(1, 1- dimethylethyl) -3- oxo -4- azaAndrost -1- ene -17- carboxamide

17beta- (n-tert-butylcarbamoyl) -4- aza -5 alfa-androst -1- en -3- Youn

N-tert-butil -3- oxo -4- aza -5 alfa-androst -1- en -17 beta-carboxamid

N-(2- methyl -2- propyl) -3- oxo -4-

4- azaAndrost -1- eNe -17- karboksamid, n- (1, 1- dimethylethyl) -3- oxo-, (5alpha, 17beta)-

(1s, 3as, 3bs, 5ar, 9ar, 9bs, 11as) -n-tert-butyl -9 a, 11a-dimethyl -7- oxo -1, 2,3 , 3a, 3b, 4,5,5a, 6,9b, 10, 11- dodecahydroindeno [5, 4- f] quinoline -1- karboksamid

(4ar, 4bs, 6as, 7s, 9as, 9bs, 11ar) -n-tert-butil -4 a, 6a-dimethyl -2- oxo -2, 4a, 4b, 5,6,6 a, 7,8,9,9a, 9b, 10,11,11a-tetradecahydro -1 h-indeno [5, 4- f] quinoline -7- carboxamide

Entadfi eleman finasteride

Finasteride

Propeshia

Finasterida

(4ar, 4bs, 6as, 7s, 9as, 9bs, 11ar) -n- (1, 1- dimethylethyl) -4 a, 6a-dimethyl -2- oxo -2, 4a, 4b , 5,6,6a, 7,8,9,9a, 9b, 10,11,11a-tetradecahydro -1 h-indeno [5, 4- f] quinoline -7- carboxamide

Andozac

 

Baj popilè: 98319-26-7 Finasteride, Lachin 98319-26-7 Finasteride manifaktirè, Swèd